首页> 外国专利> NEW DERIVATIVES BENZIMIDAZOLE AND IMIDAZOPYRIDINE AND THEIR APPLICATION AS MEDICINES

NEW DERIVATIVES BENZIMIDAZOLE AND IMIDAZOPYRIDINE AND THEIR APPLICATION AS MEDICINES

机译:新衍生物苯并咪唑和咪唑并吡啶类药物及其在药物中的应用

摘要

FIELD: chemistry.;SUBSTANCE: invention relates to new compounds with the general formula (I) in the racemic, enantiomeric form or in any combination of these forms and in which: A represents -CH2-, -C(O)-, -C(O)-C(Ra)(Rb)-; X represents -CH-; Ra and Rb independently represent the hydrogen atom or a radical (C1-C6)alkyl; Rj represents the atom of hydrogen; a radical (C1-C8)alkyl, not necessarily substituted hydroxyl or by one or more identical or different radicals of halogens; (C2-C6)alkenyl; or a radical of the formula -(CH2)n-X1; R2 represents a radical (C1-C8)alkyl not necessarily substituted hydroxyl or by one or more identical or different radicals of halogens; (C2-C6)alkenyl; or a radical of the formula -(CH2)n-X1; each X1 independently represents (C1-C6)alkoxy, (C3-C7)cycloalkyl or heteroaryl, and radicals (C3-C7)cycloalkyl, aryl and heteroaryl are not necessarily replaced by one or more either identical or various assistants chosen from: -(CH2)n'-V1-Y1, halogen and; V1 represents -O-, -S- or a covalent bond; Y1 represents a radical (C1-C6)alkyl, not necessarily substituted hydroxyl or by one or more identical or different radicals of halogens; n represents an integer from 0 up to 6 and n ' - an integer from 0 up to 2 that if n is equal 0 then X1 does not represent a radical alkoxy); or R1 and R2 form together with the atom of nitrogen to which they are attached, heterobicycloalkyl or heterocycloalkyl, are not necessarily replaced by one or more either identical or various substitutes chosen from: hydroxy, (C1-C6)alkyl, not necessarily substituted by hydroxy, (C1-C6)alkoxycarbonyl, heterocycloalkyl and-C(O)NV1'Y1', in which V1' and Y1' independently represent the atom of hydrogen or (C1-C6)alkyl; or R1 and R2 together form a radical of the formula: R3 represents-Z3, -C(RZ3)(R'Z3)-Z3, -C(RZ3)(R'Z3)-(CH2)p-Z3 or -C(O)Z'3; RZ3 and R'Z3 independently represent atom of hydrogen or a radical (C1-C6)alkyl; Z3 represents Z3b, Z3c, Z3d or Z3e; Z3b represents (C1-C6)alkoxy, (C1-C6)alkythio, (C1-C6)alkylamino, or a radical di((C1-C6)alkyl) amino; Z3c represents aryl or a radical heteroaryl; Z3d represents C1-C6)alkoxycarbonyl, aminocarbonyl, (C1-C6)alkylaminocarbonyl, di((C1-C6)alkyl) aminocarbonyl, (C1-C6)alkyl-C(O)NH-, (C3-C7) cycloalkyl, heterocycloalkyl; and radicals (C3-C7) cycloalkyl and heterocycloalkyl are not necessarily replaced by one or more either identical or various substitutes chosen from: (C1-C6)alkoxy, (C1-C6)alkylcarbonyl, (C1-C6)alkoxycarbonyl and oxy, radicals aryl and heteroaryl are not necessarily replaced by one or more either identical or various substitutes chosen from: halogen, cyanogen, nitro, azide, oxy, (C1-C6)alkylcarbonyl-(C1-C6)alkenyl, (C1-C6)alkylaminocarbonyl-(C1-C6)alkenyl, -SO2-NR31R32, heterocycloalkyl, heteroaryl or -(CH2)P'-V3-Y3; R31 and R32 form together with atom of nitrogen to which they are attached, heterocycloalkyl, V3 represents -O-, -S-, -C(O)-, -C(O)-O-, -O-C(O)-, -SO2-, -SO2NH-, -NR'3-SO2-, -NR'3-, -NR'3-C(O)-, -C(O)-NR'3-, -NH-C(O)-NR'3- or covalent bonds; Y3 represents the atom of hydrogen; radical (C1-C6)alkyl, not necessarily replaced by one or more either identical or different radicals of halogens; radical aryl or a radical aryl-(C1-C6)alkyl; Z3e represents a radical of the formula ; , Z'3 represents a radical aryl, not necessarily replaced by one or more oreither identical or various substitutes chosen from: halogen, nitro and -(CH2)P"-V'3-Y'3; V'3 represents -O-, -C(O)-, -C(O)-O, -C(O)-NR'3-,-NH-C(O)-NR'3- or covalent bonds; Y'3 represents the atom of hydrogen or a radical (C1-C6)alkyl, not necessarily replaced by one or more either identical or different radicals of halogens; R'3 represents the atom of hydrogen (C1-C6)alkyl or a radical (C1-C6)alkoxy; p represents an integer from 1 up to 4; p' and p" independently represent an integer from 0 up to 4; R4 represents a radical of the formula -(CH2)S-R'4; R'4 represents a radical guanidine; heterocycloalkyl containing, at least, one atom of nitrogen and not necessarily substituted (C1-C6)alkyl or aralkyl; heteroaryl containing, at least, one atom of nitrogen and not necessarily substituted (C1-C6)alkyl or a radical of the formula -NW4W'4; W4 represents an atom of hydrogen or (C1-C8) alkyl; W'4 represents a radical of the formula -(CH2)S-Z4; Z4 represents an atom of hydrogen (C1-C8) alkyl, (C3-C7)cycloalkyl, heteroaryl and aryl; s and s' independently represent an integer from 0 up to 6; and i) if R3 represents -C(O)-Z'3 and R4 represents a radical of the formula -(CH2)S-NW4W'4, and W4 and W'4 independently represent an atom of hydrogen or a radical C1-C6)alkyl, then -(CH2)s represents neither radical ethylene nor radical -(CH2)-CH((C1-C4)alkyl) and ii), if R3 represents -Z3c and Z3c represents phenyl or naphthyl, then phenyl and naphthyl are not substituted by cyanogen; also note that if R3 represents -Z3d, then Z3d, represents only one (C3-C7)cycloalkyl or heterocycloalkyl; or to their pharmaceutically acceptable salts. The invention also relates to the method of obtaining the compounds of the formula (I), to a pharmaceutical composition, and to the application of compounds of the formula (I) and (I ').;EFFECT: obtaining new biologically active compounds on their basis, possessing activity with respect to receptors MC4.;41 cl, 535 ex
机译:技术领域本发明涉及具有通式(I)的新化合物。<图像文件=“ 00000007.GIF” he =“ 27” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 65” />外消旋,对映体形式或这些形式的任何组合,且其中:A代表-CH 2 -,-C(O)-,-C(O)-C(R a)( R b)-; X代表-CH-; R a 和R b 独立地代表氢原子或基团(C 1 -C 6 )烷基; Rj代表氢原子; (C 1 -C 8 )烷基,不一定是取代的羟基或一个或多个相同或不同的卤素基团; (C 2 -C 6 )烯基;或式-(CH 2 n -X 1 的基团; R 2 表示基团(C 1 -C 8 )烷基,其不一定取代羟基或被一个或多个相同或不同的卤素基团取代; (C 2 -C 6 )烯基;或式-(CH 2 n -X 1 的基团;每个X 1 分别代表(C 1 -C 6 )烷氧基,(C 3 -C 7 )环烷基或杂芳基,基团(C 3 -C 7 )环烷基,芳基和杂芳基不一定要被一个或多个相同或不同的取代选自以下的助剂:-(CH 2 n' -V 1 -Y 1 ,卤素和; V 1 代表-O-,-S-或共价键; Y 1 表示基团(C 1 -C 6 )烷基,不一定取代羟基或被一个或多个相同或不同的卤素基团取代; n表示从0到6的整数,n'-表示从0到2的整数,如果n等于0,则X 1 不代表自由基烷氧基。或R 1 和R 2 形式与它们所连接的氮原子杂二环烷基或杂环烷基一起,不一定要被一个或多个相同或多种取代基取代选自:羟基,(C 1 -C 6 )烷基,不一定被羟基取代,(C 1 -C 6 )烷氧羰基,杂环烷基和-C(O)NV 1 'Y 1 ',其中V 1 '和Y < Sub> 1 '独立地代表氢或(C 1 -C 6 )烷基的原子;或R 1 和R 2 共同构成以下公式的基本形式: <图像文件=” 00000009.GIF“ he =” 18“ imgContent =” undefined“ imgFormat =” GIF“ wi =” 15“ /> <图像文件=” 00000010.GIF“他=“ 15” imgContent =“未定义” imgFormat =“ GIF” wi =“ 29” /> R 3 代表-Z 3 ,-C(R Z3 )(R' Z3 )-Z 3 ,-C(R Z3 )(R' Z3 )-(CH 2 p -Z 3 或-C(O)Z' 3 ; R Z3 和R' Z3 独立地代表氢原子或基团(C 1 -C 6 )烷基; Z 3 表示Z 3b ,Z 3c ,Z 3d 或Z 3e ; Z 3b 表示(C 1 -C 6 )烷氧基,(C 1 -C 6 < / Sub>)烷硫基,(C 1 -C 6 )烷基氨基或基团di(((C 1 -C 6 )烷基)氨基; Z 3c 表示芳基或杂芳基。 Z 3d 表示C 1 -C 6 )烷氧羰基,氨基羰基,(C 1 -C 6 )烷基氨基羰基,二((C 1 -C 6 )烷基)氨基羰基,(C 1 -C 6 )烷基-C(O)NH-,(C 3 -C 7 )环烷基,杂环烷基; (C 3 -C 7 )环烷基和杂环烷基不一定要被一个或多个相同或多种选自以下的取代基取代:(C 1 -C 6 )烷氧基,(C 1 -C 6 )烷基羰基,(C 1 -C 6 )烷氧羰基和氧基,芳基和杂芳基不一定要被一个或多个相同或多种选自以下的取代基取代:卤素,氰,硝基,叠氮化物,氧基,(C 1 < / Sub> -C 6 )烷基羰基-(C 1 -C 6 )烯基,(C 1 - C 6 )烷基氨基羰基-(C 1 -C 6 )烯基,-SO 2 -NR 31 R 32 ,杂环烷基,杂芳基或-(CH 2 P '-V 3 -Y 3 ; R 31 和R 32 与它们所连接的氮原子一起形成,杂环烷基,V 3 表示-O-,-S- ,-C(O)-,-C(O)-O-,-OC(O)-,-SO 2 -,-SO 2 NH-,- NR' 3 -SO 2 -,-NR' 3 -,-NR' 3 -C(O )-,-C(O)-NR' 3 -,-NH-C(O)-NR' 3 -或共价键; Y 3 代表氢原子; (C 1 -C 6 )烷基,不一定被一个或多个相同或不同的卤素基团取代;芳基或芳基-(C 1 -C 6 )烷基; Z 3e 表示公式 ; ,Z' 3 表示基团芳基,不一定被一个或多个或相同或多种选自以下的取代基取代:卤素,硝基和-(CH 2 P“ -V' 3 -Y' 3 ; V' 3 表示-O-,-C(O)- ,-C(O)-O,-C(O)-NR' 3 -,-NH-C(O)-NR' 3 -或共价键; Y' 3 表示氢原子或基团(C 1 -C 6 )烷基,不一定被一个或多个相同的取代或不同的卤素基团; R' 3 表示氢原子(C 1 -C 6 )烷基或基团(C 1 -C 6 )烷氧基; p表示1至4的整数; p'和p“独立地表示0至4的整数; R 4 表示式-(CH 2 S -R' 4 的基团; R' 4 代表一个胍基。含有至少一个氮原子且不一定取代的(C 1 -C 6 )烷基或芳烷基的杂环烷基;包含至少一个氮原子且不一定取代的(C 1 -C 6 )烷基或通式-NW 4 的基团的杂芳基Sub> W' 4 ; W 4 代表氢或(C 1 -C 8 )烷基的原子; W' 4 表示式-(CH 2 S -Z 4 的基团; Z 4 表示氢原子(C 1 -C 8 )烷基,(C 3 -C < Sub> 7 )环烷基,杂芳基和芳基; s和s'独立表示0到6之间的整数;和i)如果R 3 表示-C(O)-Z' 3 并且R 4 表示式-(CH < Sub> 2 S -NW 4 W' 4 和W 4 和W' 4 独立地表示氢原子或基团C 1 -C 6 )烷基,然后是-(CH 2 >) s 既不表示基团的乙烯也不表示基团-(CH 2 )-CH((C 1 -C 4 )烷基)和ii),如果R 3 代表-Z 3c 和Z 3c 代表苯基或萘基,则苯基和萘基不被氰取代;还应注意,如果R 3 代表-Z 3d ,则Z 3d 仅代表一个(C 3 - C 7 )环烷基或杂环烷基;或其药学上可接受的盐。本发明还涉及获得式(I)的化合物的方法,药物组合物以及式(I)和(I')的化合物的应用。效果:在其上获得新的生物活性化合物它们的基础,具有针对受体MC4的活性。; 41 cl,535 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号